Empresário Elon Musk tem uma nova empresa — sim, outra — focada no desenvolvimento das capacidades do cérebro através do aumento tecnológico. O Neuralink, vai trabalhar em tecnologia de interface computador-cérebro como meio de ajudar os seres humanos a acompanhar o desenvolvimento acelerado de inteligência artificial.
This is big: Is the Singularity a step closer?
Tesla Inc founder and Chief Executive Elon Musk has launched a company called Neuralink Corp through which computers could merge with human brains, the Wall Street Journal reported, citing people familiar with the matter.
Neuralink is pursuing what Musk calls the “neural lace” technology, implanting tiny brain electrodes that may one day upload and download thoughts, the Journal reported. (on.wsj.com/2naUATf)
“In today’s world, we are increasingly hearing calls for global competencies; that is, we are seeing demand for skills such as critical thinking and creativity across both manual and professional occupations.”
An exclusive interview with Ichor, the biotech company pioneering a SENS based repair therapy that could help cure age related blindness.
Check out our exclusive interview with Ichor the company taking the first SENS based therapy to the clinic. Should clinical trials be a success this will mark the arrival of a technology that addresses one of the aging processes.
Driverless vehicles operated by Uber Technologies Inc [UBER.UL] were back on the road in San Francisco on Monday after one of its self-driving cars crashed in Arizona, the ride-hailing company said.
Uber’s autonomous vehicles in Arizona and Pittsburgh, Pennsylvania, remained grounded but were expected to be operating again soon, according to a spokeswoman for the company, who refused to be identified.
“We are resuming our development operations in San Francisco this morning,” she said in an email.
Continue reading “Uber resumes self-driving car program in San Francisco after crash” »
Are 3D printed pills the future? We visited a London laboratory to find out.
Established by academics from University College London (UCL) in 2014, FabRx is a company seeking commercialize 3D printed medicines and devices. On the principle that everyone is different, the vision of 3D printed pills it to be able to provide more personal and specific care to patients in need.
Dr. Alvaro Goyanes is one of the four founding partners of FabRx and the company’s director of development. Dr. Goyanes invited 3D Printing Industry into the lab at UCL’s School of Pharmacy to find out more about the ongoing FabRx research.
Continue reading “3D printed pills: interview with FabRx at University College London” »
Is the risk of cultural stagnation a valid objection to rejuvenation therapies? You guessed it—nope.
This objection can be discussed from both a moral and a practical point of view. This article discusses the matter from a moral standpoint, and concludes it is a morally unacceptable objection. (Bummer, now I’ve spoiled it all for you.)
However, even if the objection can be dismissed on moral grounds, one may still argue that, hey, it may be immoral to let old people die to avoid cultural and social stagnation, but it’s still necessary.
Continue reading “Rejuvenation would cause cultural stagnation” »
https://www.youtube.com/watch?v=xGZSm-6ng9k
Amazing Genes are HIDDEN inside of us; Science has found it. In 2014 one of the craziest science experiments by some incredible scientists at Oxford University found that less than 10% of human DNA is active, meaning that the majority of your genetic code is just sitting around doing nothing.
Narration provided by JaM Advertising New Mexico www.tasteofjam.com
Continue reading “10 AMAZING Abilities HIDDEN in Your GENES” »
Newyorker article about aging research. At least they gave both the conservative and more progressive camps a mention though it appears the author sides with the healthspan crowd.
A large article in the newyorker about longevity research. The conservative and the more radical approaches are discussed including SENS.
Amusing to note that the mainstream are portrayed as healthspanners and dont think its possible to comprehensively fix aging. Looks like we have much work to do to change that view.
Hedge funds have been trying to teach computers to think like traders for years.
Now, after many false dawns, an artificial intelligence technology called deep learning that loosely mimics the neurons in our brains is holding out promise for firms. WorldQuant is using it for small-scale trading, said a person with knowledge of the firm. Man AHL may soon begin betting with it too. Winton and Two Sigma are also getting into the brain game.
